Has Biotech Reached Its Peak? Analysts Say Room for Growth
Put a bunch of seasoned biotech investor veterans on stage and you are sure to attract an audience. That was certainly the case for "Forecasting 2013: Trick or Treat?" the closing plenary session of the BIO Investor Forum in San Francisco last week, which had a standing room-only crowd.